Skip to content
中文产业新闻精选评分76Chinese source

强生口服IL-23R拮抗剂icotrokinra在国内获批上市

强生全球首创口服IL-23R拮抗剂国内获批上市

Original articleChinese edition

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.